Complementary and Alternative Healing University |
See more menu at the bottom of page
Human Herpes virus type 6 (HHV-6)人類皰疹病毒6型 HHV-6 was first discovered in 1986. It was discovered by studying the patients with lymphatic cell hyperplasia and patients with HIV. The virus possesses the shape of herpes viruses and like to attach to the lymph cells. It was called HHV-6 because it was new at the time of discovery, besides the other 5 types of viruses already had been discovered. This virus infects human white blood cells, specifically T lymphocytes. Usually children get this HHV-6 infection before 2 years old. Using immunofluorescence technique, 60 to 80 % of the population show the HHV-6 antigen in the serum. Most people infected with HHV-6 do not show symptoms. Symptomatic infections typically induces exanthema subitum (roseola infantum). More severe primary infections may include hepatitis, inflammation of the brain and mengis, interstitial pneumonia, and mononucleosis like syndrome. In patients using immune system suppressing drugs, such as transplant recipients, HHV-6 primary infection or reactivation patients may induce a rejection of transplanted organs and death. Diagnosis: fever with lymphadenopathy (chronic enlargement of lymph nodes), a mononucleosis-like disease with negative test results for acute CMV and EBV infection. In children under 2 years of age usually show febrile seizures. Treatments include using phosphono formic acid (PFA) and phosphono acetic acid ( PAA). This kind of virus have a lipid shell which is difficult for the immune system to kill. A common preservative, BHT has been used and there report of its efficacy.
The 5 types of common herpes viruses before the discovery of HHV-6: [1]
Mononeuclosis: symptoms are fever, severe sore throat, swollen glands, and fatigue. Serious symptoms can include abdominal pain which may suggest inflamed spleen and/or inflamed liver. Difficulty in breathing may suggest that the glands in the throat can be swollen. Blood test will show large number of single nucleus white cells. [1] answers.com 人類皰疹病毒6型(Human Herpes virus type 6,HHV-6)是1986年從淋巴增殖異常患者及愛滋病病人外週血單細胞首先分離到一種具有皰疹病毒形態和嗜淋巴 細胞的新病毒,它與已知的5個皰疹病毒 的抗原性和酶切圖譜不同,故名HHV-6。 人類感染HHV-6十分普遍, 但多為隱性感染。免疫熒光試驗可在60~80%兒童及成人血清中查到HHV-6抗體。HHV-6是嬰兒急疹(玫瑰疹)的病原,並證實與淋巴增殖性疾病、自 身免疫病和免疫缺陷病人感染等有關。隨著器官移植的發展和愛滋病病人的增多,HHV-6感染變得日益重要。 微生物學檢查,可採取早期病人 外週血單核細胞與經活化(用PHA、IL2)的臍帶血淋巴細胞共培養,或用活化的T細胞系(為HSB2)感染病人體液(唾液、尿液、血液等)進行病毒分離 。亦可用原性雜交和PCR技術檢測感染細胞或組織中病毒DNA。及血清學試驗(IFA,ELISA)檢測抗病毒lgM和lgG,以確定近期感染和流行病學 調查。 常用治療藥物是磷乙酸和磷甲酸 ,兩者均可抑制病毒聚合酶viral polymerase 的活性,阻斷DNA復制。 磷甲酸和磷乙酸是焦磷酸類似物,當 RNA和 DNA合成時它干擾聚 合酶接觸到三磷酸核苷,PFA和 PAA的三鈉鹽抑制病毒聚合酶活力所需濃度遠在封閉宿主細胞的聚合酶活力所需濃度之下,因此它是一個很有用的抗病毒化合 物。1979年Nordenfelt等在瑞典証明,PFA在試管內是一個有力的HBV-DNAP抑制劑。 1980年 Hess等在西德証明 PFA是 HBV DNAP的非競爭抑制劑,它似乎是與延長的DNA分子焦磷酸結合位點相互作用。有報道PFA可引起血清DNAP水平的抑制及肝細胞內HBcAg 反 應性降低。腸道外應用PFA治療慢性乙肝病人的報告尚不多見。
Problems with website? Please Click here for comment. (Not for inquiry ) 按此看關於版權問題Sponsors' Ads by Google 以下為谷歌 所提供之廣告
|